Moderna announced that they will request Emergency Use Authorization for their Covid-19 vaccine from the U.S. Food and Drug Administration [FDA] and conditional approval from the European Medicines Agency [EMA] today. A statement from the company said “that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the […]
|